Wolverine blend 10 mg / BPC-157 + Tb4 (TB-500)

Description

Wolverine Blend is a two-peptide research formulation containing:

• BPC-157 – 5 mg
• TB-500 (Full Sequence Thymosin β4) – 5 mg

The name “Wolverine” originates from the comic-book character known for rapid healing and has become community shorthand for the combination of BPC-157 and TB-500. While the name is widely recognised within peptide research communities, it does not refer to a distinct molecule or independently studied peptide. Instead, it describes a formulation that combines two of the most extensively investigated regenerative peptides into a single vial.

Why Wolverine Blend matters in regenerative research

BPC-157 and TB-500 are frequently discussed together because published research on each peptide explores different aspects of tissue repair.

Within the scientific literature, researchers have investigated:

BPC-157

• tendon biology
• ligament repair
• angiogenesis
• gastrointestinal biology
• nitric oxide signalling

TB-500 (Thymosin β4)

• cell migration
• actin dynamics
• tissue remodelling
• angiogenesis
• wound-healing biology

By combining these two well-known regenerative peptides into a single formulation, Wolverine Blend provides researchers with a convenient way to investigate complementary repair-related pathways. Current scientific evidence, however, relates primarily to the individual peptide components, rather than to the blend itself.

The two components of Wolverine Blend

BPC-157 (5 mg)

A stable gastric pentadecapeptide widely investigated in tendon, ligament, muscle, gastrointestinal and angiogenesis research. BPC-157 has become one of the most recognised regenerative peptides because of its broad preclinical literature involving soft-tissue biology.

TB-500 (5 mg)

This product contains full-sequence Thymosin β4, the naturally occurring 43-amino-acid peptide that underpins TB-500 biology. Published research has investigated Thymosin β4 in relation to cell migration, actin regulation, angiogenesis and tissue remodelling.

Together, these peptides represent two complementary areas of regenerative research while maintaining their own independent scientific evidence base.

Why Wolverine Blend is widely investigated in musculoskeletal research

Wolverine Blend has become one of the most recognised peptide combinations in sports medicine and musculoskeletal research communities because both of its components have been extensively investigated in experimental models involving connective tissue repair.

Published research on the individual peptides includes studies of:

• tendon biology
• ligament repair
• skeletal muscle
• connective tissue remodelling
• angiogenesis
• wound healing
• soft-tissue regeneration

Because these research areas frequently overlap, combining BPC-157 and TB-500 into a single formulation has become a common approach in laboratory research. However, published evidence should be interpreted according to the literature available for each individual peptide rather than assumed to demonstrate equivalent findings for the combined formulation.

Why Wolverine Blend differs from GLOW and KLOW

Although all three formulations belong to the Healing & Recovery category, they are designed around different research concepts.

Wolverine Blend

•  BPC-157
• TB-500

Focus on soft-tissue and musculoskeletal research

GLOW Blend

• GHK-Cu
• BPC-157
• TB-500

Expanded focus including extracellular matrix biology and connective tissue remodelling

KLOW Blend

• GHK-Cu
• BPC-157
• TB-500
• KPV

Broader research scope that also includes inflammation-related pathways

Researchers choose between these formulations based on the biological pathways they wish to investigate rather than on one blend being universally superior.

Human and preclinical research

There are currently no large published clinical studies evaluating Wolverine Blend as a combined formulation. Instead, the scientific rationale for the blend is based on the substantial independent literature describing:

BPC-157 in musculoskeletal and gastrointestinal research
Thymosin β4/TB-500 in cell migration, angiogenesis and tissue-remodelling research

Accordingly, Wolverine Blend should be viewed as a research formulation built from two individually investigated peptides rather than as a molecule with its own independent clinical evidence base.

Published safety considerations

Published safety observations for Wolverine Blend are derived from the available literature on BPC-157 and Thymosin β4/TB-500 individually. Because the combination itself has not been evaluated in dedicated large clinical studies, findings reported for either peptide should not automatically be assumed to apply to the blend as a whole.

Product characteristics

Application: laboratory and analytical research
Use restriction: not for human consumption; not for medical, veterinary or cosmetic use
Produced in GMP-compliant facilities under strict QC protocols.
Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures).
Freeze-dried (lyophilized) for maximum stability and extended shelf life.
Sealed in sterile vials, ready for reconstitution.

Purity: ≥ 99% (HPLC)
Appearance: white lyophilized powder
Composition: 5 mg BPC-157 + 5 mg Thymosin Beta-4 (full sequence)
Molecular formula BPC-157: C₆₂H₉₈N₁₆O₂₂
Molecular formula Thymosin Beta-4 (full sequence): C₂₁₄H₃₅₃O₇₉N₅₇S₁
Storage: unopened lyophilized vials are best stored refrigerated at 2–8°C, which is the storage method confirmed by our manufacturing partner and suitable for up to 24 months. Refrigeration is preferred because it minimizes unnecessary freeze–thaw cycles during routine handling. If substantially longer-term storage is required, unopened lyophilized vials may also be kept frozen. Once reconstituted, always store at 2–8°C and do not freeze.

Reconstitution and handling

Wolverine is supplied as a lyophilised vial and should be handled using standard peptide reconstitution procedures appropriate to the research setting. Must be reconstituted with bacteriostatic water before use. To help preserve structural integrity, add the chosen solvent slowly against the inside wall of the vial rather than directly onto the peptide cake, and avoid vigorous shaking. Gentle swirling is generally sufficient once the peptide has fully dissolved. Standard laboratory practice also includes allowing refrigerated vials to reach room temperature before reconstitution to minimise condensation inside the vial.

For other solvent selection, concentration planning and storage guidance, see the full Peptide Reconstitution Guide and Reconstitution Calculator.

Key published studies

• Sikiric P, Seiwerth S, Rucman R, et al. Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract. Current Pharmaceutical Design, 2011.

A foundational review describing BPC-157 biology, tissue repair research and gastrointestinal protection.

• Chang CH, Tsai WC, Hsu YM, et al. Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts. Molecular Medicine Reports, 2014.

A landmark tendon biology study supporting BPC-157’s importance in connective tissue research.

• Goldstein AL, Kleinman HK. Thymosin β4: Structure, Function and Biological Properties Supporting Current and Future Clinical Applications. Annals of the New York Academy of Sciences, 2010.

The definitive review describing full-sequence Thymosin β4 biology, angiogenesis, cell migration and regenerative signalling.

• Xing Y, Zhang Y, Li Y, et al. Progress on the Function and Application of Thymosin β4. International Journal of Molecular Sciences, 2021.

A comprehensive review summarising current understanding of Thymosin β4 in tissue repair and regenerative medicine.

Frequently Asked Questions

What is Wolverine Blend?

Wolverine Blend is a research formulation combining BPC-157 (5 mg) and TB-500 (Full Sequence Thymosin β4, 5 mg) in a single lyophilised vial. It is one of the best-known peptide combinations in regenerative research and is widely discussed in relation to tissue repair, tendon biology and musculoskeletal research.

Which peptides are included in Wolverine Blend?

Each vial contains:

BPC-157 – 5 mg
TB-500 (Full Sequence Thymosin β4) – 5 mg

These peptides have different but complementary research profiles. BPC-157 is commonly investigated in soft-tissue and gastrointestinal models, while TB-500 is associated with cell migration, angiogenesis and tissue remodelling.

Why are BPC-157 and TB-500 often combined?

Researchers frequently discuss these peptides together because they have been investigated in complementary areas of regenerative biology. BPC-157 is commonly associated with tendon, ligament and angiogenesis research, whereas TB-500 is primarily linked to Thymosin β4 biology, cell migration and tissue remodelling. The scientific rationale for the blend is based on these complementary mechanisms rather than on dedicated studies of the combined formulation.

What research areas commonly investigate Wolverine Blend?

Based on the published literature for its individual components, Wolverine Blend is relevant to research involving tendon and ligament biology, skeletal muscle, connective tissue repair, angiogenesis, wound healing, musculoskeletal research and regenerative biology.

How does Wolverine Blend differ from GLOW Blend?

Wolverine Blend combines BPC-157 and TB-500 only. GLOW Blend adds GHK-Cu, expanding the research focus to extracellular matrix biology, collagen regulation and connective tissue remodelling. Researchers choose between the formulations according to the biological pathways they wish to investigate.

Can findings from BPC-157 and TB-500 be applied directly to Wolverine Blend?

Not necessarily. Both peptides have substantial independent research literature, but there are currently no large published clinical studies evaluating the complete Wolverine Blend formulation. For this reason, findings should be interpreted according to the evidence available for each individual peptide rather than assumed to apply directly to the blend.

Is this product intended for human use?

No. Wolverine Blend supplied by LIFE Peptide is provided strictly for laboratory and analytical research. It is not intended for human consumption, diagnosis, treatment or prevention of disease. Any discussion of published studies summarises the scientific literature relating to the individual peptide components rather than the intended use of the combined formulation.

Related research context

WOLVERINE belongs to the Healing & recovery peptide research category, combining two complementary compounds commonly investigated for tissue-response and regenerative signaling pathways.
Researchers exploring broader recovery models may also examine:
BPC-157 — tissue signaling and angiogenesis research
TB-500 (Thymosin β4) — migration and cytoskeletal pathway research
GHK-Cu — extracellular remodeling and skin-related peptide signaling
GLOW — multi-pathway blend combining GHK-Cu, BPC-157, and TB-500
For broader context, see the Healing & recovery research guide.

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.